Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on precision medicines for neuropsychiatric disorders, today announced the presentation of data from a ...
On the evening of Thursday, March 18, a group of Scott City High School students attended the program "Navigating the Hemispheres of Neuroscience" presented by Scott R. Gibbs, MD, FACS and hosted by ...
Results Show Continued Safety, Tolerability, and Sustained Clinical Benefit Including Improvements in Function, Physician- and Patient-Reported Outcomes, and Quality-of-Life This Personalized ...
WALTHAM, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sironax, a global clinical-stage biotechnology company dedicated to discovering and developing transformative therapies for age-related degenerative ...
A new synthesis of psychological phenomena, neuroscience, and authentic delivery offers fresh insights for public speakers ...
Patients with implanted neural devices offer researchers unique opportunities to study the basic workings of the human brain. This is made possible by patients undergoing epilepsy monitoring or the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results